GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

It is the first biosimilar of a rapid-acting insulin product – used to control the blood glucose spike after meals – and only the third insulin biosimilar to be approved in the US. Novo ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin degludec) got US approval late last year. [caption id ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

One of the standout features of Aqua Sculpt is its customer-first refund policy. If you're not fully satisfied with your ...

A fictional clinical study, published in the Journal of Gut Dermatology in late 2024, reported that participants using a ...

As the biological diversity of these tumours and their rarity have made conducting large-scale clinical trials ... conventional therapies have fallen short." Dr. Tan Boon Toh, Head of the ...

Insulin Lispro. The first rapidly acting analogue developed was approved for clinical use in 1996. It is obtained by inverting of the lysine at position 28 and the proline at position 29 on the ß ...

55.9) on a 90-point scale, highlighting broader nutritional ... producing compounds like short-chain fatty acids (SCFAs) that guide healthy immune maturation. Monounsaturated fats in avocado ...